About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
San Diego Cardiovascular Interventions (SDCI) 2019
INTERVENTIONAL PHARMACOTHERAPY: CASE-BASED MANAGEMENT
STRUCTURAL HEART INTERVENTIONS II: CASE-BASED MANAGEMENT
STRUCTURAL HEART INTERVENTIONS I: CASE-BASED MANAGEMENT
IMAGING, PHYSIOLOGY AND COMPLICATIONS
INTERVENTIONAL ROBOTICS
COMPLEX AND HIGH-RISK INTERVENTIONAL PROCEDURES II
COMPLEX AND HIGH-RISK INTERVENTIONAL PROCEDURES I
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
DOACs and Thienopyridines in the Management of ACS
By
San Diego Cardiovascular Interventions (SDCI) 2019
FEATURING
Jonathan Hsu
By
San Diego Cardiovascular Interventions (SDCI) 2019
FEATURING
Jonathan Hsu
283 views
September 17, 2019
0 Comments
Login to view comments.
Click here to Login
INTERVENTIONAL PHARMACOTHERAPY: CASE-BASED MANAGEMENT
19:00
San Diego Cardiovascular Interventions (SDCI) 2018
Intravenous ADP Antagonist for PCI
Feat.
M. Patel
10:46
San Diego Cardiovascular Interventions (SDCI) 2019
Utility of GP IIb / IIIa Inhibitors in Contemporary PCI
Feat.
P. Meraj
15:16
San Diego Cardiovascular Interventions (SDCI) 2018
Duration of Oral Antiplatelet Therapy After Complex PCI
Feat.
T. Henry
19:18
San Diego Cardiovascular Interventions (SDCI) 2018
Antiplatelet Therapy or Anticoagulation after TAVR
Feat.
O. Ben-Yehuda
17:02
San Diego Cardiovascular Interventions (SDCI) 2019
DOACs and Thienopyridines in the Management of ACS
Feat.
J. Hsu